Awarded to
- Awarded value
- €6,517,643
- Bids received
- 132 over 35 lots
- Record with this buyer
- 2 contracts from this buyer in the register, €7.1M in total
Description
35 lots
- Lot 1
- Combinatii Bictegravirum+ Emtricitabinum+ Tenofovirum 50mg/ 200mg/ 25mg compr filmate estimated €2,969,788 · 36 months · Antivirals for systemic use
- Lot 2
- Acidum clodronicum 300 mg/ 5 ml conc pt sol perf flacon estimated €2,719 · 36 months
- Lot 3
- Acidum zoledronicum 4mg/ 5ml conc pt sol perf flacon estimated €21,324 · 36 months
- Lot 4
- Acidum zoledronicum 4mg/ 100 ml conc pt sol perf flacon estimated €7,089 · 36 months
- Lot 5
- Bevacizumabum 25 mg/ ml-16 ml concentrat (400mg) conc.pt.sol perf flacon estimated €447,646 · 36 months
- Lot 6
- Bevacizumabum 25 mg/ ml- 4 ml concentrat (100mg) conc pt sol perf flacon estimated €77,517 · 36 months
- Lot 7
- Carboplatinum 10mg/ml - 15 ml concentrat (150mg) conc.pt.sol perf flacon estimated €19,756 · 36 months
- Lot 8
- Carboplatinum 10mg/ml - 45 ml concentrat (450mg) conc pt sol perf flacon estimated €72,816 · 36 months
- How tenders are scored
- Pretul ofertei; Termen de furnizare The lots are scored differently: the official notice gives each lot its own criteria.
Show 27 more lots
- Lot 9
- Docetaxelum 20mg/ml conc.pt.sol perf flacon 1 ml ce contine 20 mg docetaxel estimated €9,322 · 36 months
- Lot 10
- Docetaxelum 80mg/4ml conc pt sol perf flacon 4 ml ce contine 80 mg docetaxel estimated €27,139 · 36 months
- Lot 11
- Epirubicinum 2mg/ml - 50 ml sol.inj.x100mg (100mg/ 50ml) sol inj./perf flacon estimated €14,110 · 36 months
- Lot 12
- Filgrastimum 30MU/ 0,5 ml sol.inj/ perf seringa preumpluta estimated €40,709 · 36 months
- Lot 13
- Filgrastimum 48MU/ 0,5 ml sol.inj/ perf seringa preumpluta estimated €39,480 · 36 months
- Lot 14
- Fludarabinum 25mg/ml-5ml cu pulb.pt.sol. continand 50mg fludarabina pulb.pt. sol.inj./ perf flacon estimated €9,749 · 36 months
- Lot 15
- Fluorouracilum 50mg/ml- 20 ml concentrat-conc.pt.sol. inj/ perf.-flacon estimated €8,754 · 36 months
- Lot 16
- Gemcitabinum 100mg/ml x10m conc.pt.sol perfl flacon estimated €5,854 · 36 months
- Lot 17
- Gemcitabinum 38mg/mlxm -5,26 ml conc. pt.sol.perf. care contine 200mg gemcitabina conc.pt.sol perf flacon estimated €19,061 · 36 months
- Lot 18
- Gemcitabinum 38mg/mlxm -5,26 ml conc. pt.sol.perf. care contine 200mg gemcitabina conc.pt.sol perf flacon estimated €56,202 · 36 months
- Lot 19
- Gemcitabinum 38mg/mlxm -52,6 ml conc. pt.sol.perf. care contine 2000mg gemcitabina conc.pt.sol perf flacon estimated €28,438 · 36 months
- Lot 20
- Irinotecanum 20mg/ml- 5ml conc.pt. sol conc.pt.sol perf flacon estimated €10,238 · 36 months
- Lot 21
- Irinotecanum 20mg/ml-15 ml conc.pt. sol conc.pt.sol perf flacon estimated €33,672 · 36 months
- Lot 22
- Mitoxantronum 2mg/ml-10ml concentrat conc.pt.sol inj. flacon estimated €36,821 · 36 months
- Lot 23
- Obinutuzumabum 1000 mg -flac de 50ml care contine 40 ml conc -conc.pt. sol conc.pt.sol perf flacon estimated €1,076,557 · 36 months
- Lot 24
- Oxaliplatinum 5mg/ml -50 mg conc.pt.sol perf flacon estimated €13,230 · 36 months
- Lot 25
- Oxaliplatinum 5mg/ml -100 mg -conc.pt. sol conc.pt.sol perf flacon estimated €24,294 · 36 months
- Lot 26
- Paclitaxelum 6mg/ml-30mg conc- conc.pt.sol perf flacon estimated €16,288 · 36 months
- Lot 27
- Paclitaxelum 6mg/ml-150mg conc-conc.pt. sol conc.pt.sol perf flacon estimated €50,970 · 36 months
- Lot 28
- Polatuzumab vedotin 20mg/ml - flacon ce contine 30 mg polatuzumab vedotin- pulb.pt. conc.pt sol. perf. flacon estimated €252,256 · 36 months
- Lot 29
- Polatuzumab vedotin 20mg/ml - flacon ce contine 140 mg polatuzumab vedotin -pulb.pt. conc.pt sol. perf flacon estimated €587,116 · 36 months
- Lot 30
- Rituximabum 10mg/ ml- 500mg -conc.pt sol. perf. flacon estimated €195,860 · 36 months
- Lot 31
- Rituximabum 10mg/ ml- 100mg -conc.pt sol. perf flacon estimated €78,550 · 36 months
- Lot 32
- Trastuzumabum 150mg- pulb pt conc.pt.sol perf - flacon estimated €179,019 · 36 months
- Lot 33
- Vincristinum 1mg/ml-conc.pt sol. perf flacon estimated €6,455 · 36 months
- Lot 34
- Cladribinum 2mg/ ml sol inj- flacon estimated €184,309 · 36 months
- Lot 35
- Brentuximab vedotin 50mg- pulb. pt.conc.pt sol. perf flacon estimated €236,282 · 36 months
As the official notice states them.
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 59 minutes ago
What this buyer has paid before
Based on 165 comparable contracts this buyer awarded in this sector over the last 4 years.
- This award
- €6.5M
- Estimated value
- €6.9M
- Median award
- €293,873
- Middle half of past awards
- €126,529 to €594,834
The award is larger than three in four past awards.
Most recent awards
- România - Produse farmaceutice - Acord cadru furnizare medicamente PN 9 €308,008
- România - Produse farmaceutice - Acord cadru furnizare medicamente Programe Nationale 7 €10,792,123
- România - Antivirale pentru uz sistemic - ACORD CADRU FURNIZARE MEDICAMENTE PROGRAME NATIONALE 4 €2,025,982
- România - Antineoplazice - ACORD CADRU furnizare medicamente PROGRAME NATIONALE €4,624,037
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
The buyer
Full buyer profileSPITALUL JUDETEAN DE URGENTA RESITA
- notices in the register
- 196
- awards
- 184
- awarded in total
- €128.1M
Who wins its contracts
Many suppliers- different companies won its awards
- 88
- of the awards went to the three most frequent winners
- 19%
- of its calls state an estimated value
- 33%
Based on 183 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.7
- of those lots received a single tender
- 27%
- of the awards went to companies based in another country
- 0%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Awards most often to
Market context
- open now in Medical equipment & pharmaceuticals
- 8,536
- median open notice
- €294,396
Who wins in this market
Many suppliersRomania · Medical equipment & pharmaceuticals
- different companies won awards here
- 6,888
- of the awards went to the three most frequent winners
- 2%
- buyers awarded contracts here
- 483
Based on 10,055 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 2.2
- of those lots received a single tender
- 28%
- of the awards went to companies based in another country
- 1%
- of the tenders came from another country
- 4%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Similar tenders
Open now
5
days left
€7,845,987
est. value
20
days left
€3,887,969
est. value
9
days left
€1,751,485
est. value
19
days left
€2,000,983
est. value
Awarded before
Never miss a tender like this
223 new notices in Medical equipment & pharmaceuticals in Romania in the last 7 days. Get an email when new ones appear. Free.
Set up my alertOr follow just its CPV code, Antineoplastic agents: an email when new tenders arrive under it, no account needed.